pantoprazole has been researched along with mycophenolic acid glucuronide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bucher, M; Faerber, L; Fischer, W; Kees, F; Raspé, A; Rupprecht, K; Schmidt, C; Schweda, F; Shipkova, M | 1 |
| Brakemeier, S; Budde, K; Dürr, M; Glander, P; Halleck, F; Hambach, P; Klonower, D; Mai, M; Neumayer, HH; Rissling, O; Schrezenmeier, EV; Singer, E | 1 |
2 trial(s) available for pantoprazole and mycophenolic acid glucuronide
| Article | Year |
|---|---|
Bioavailability of mycophenolate mofetil and enteric-coated mycophenolate sodium is differentially affected by pantoprazole in healthy volunteers.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Biological Availability; Drug Interactions; Female; Glucuronides; Humans; Immunosuppressive Agents; Male; Mycophenolic Acid; Pantoprazole; Tablets, Enteric-Coated; Time Factors | 2009 |
No relevant pharmacokinetic interaction between pantoprazole and mycophenolate in renal transplant patients: a randomized crossover study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Cross-Over Studies; Drug Interactions; Enzyme Inhibitors; Female; Glucuronides; Humans; Immunosuppressive Agents; IMP Dehydrogenase; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Pantoprazole; Tablets, Enteric-Coated; Therapeutic Equivalency | 2015 |